How much revenue did PeptiDream generate this year?
PeptiDream has achieved a revenue of 46.62 B JPY this year.
PeptiDream Revenue 2024
PeptiDream Revenue
46.62 B JPY
Ticker
4587.T
ISIN
JP3836750004
WKN
A1W0KK
In 2024, PeptiDream's sales reached 46.62 B JPY, a 62.36% difference from the 28.71 B JPY sales recorded in the previous year.
The PeptiDream Revenue history
| YEAR | REVENUE (undefined JPY) | GROSS MARGIN (%) |
|---|---|---|
| 2026e | 44.31 | 38,86 |
| 2025e | 41.61 | 41,38 |
| 2024e | 46.62 | 36,94 |
| 2023 | 28.71 | 59,97 |
| 2022 | 26.85 | 67,46 |
| 2021 | 9.42 | 74,60 |
| 2020 | 11.68 | 81,61 |
| 2019 | 1.04 | 35,28 |
| 2018 | 7.22 | 77,12 |
| 2017 | 6.43 | 72,33 |
| 2016 | 4.9 | 72,22 |
| 2015 | 4.33 | 74,90 |
| 2014 | 2.47 | 70,84 |
| 2013 | 0.82 | 61,56 |
| 2012 | 0.68 | 60,55 |
| 2011 | 0.27 | 37,77 |
| 2010 | 0.6 | 80,20 |
| 2009 | 0.09 | 30,95 |
| 2008 | 0.09 | 43,96 |
| 2007 | 0.06 | 51,58 |
PeptiDream Revenue, EBIT, Net Income JP3836750004 · A1W0KK
3 years
5 years
10 years
25 Years
Max
Revenue
EBIT
Net Income
Details
Revenue, EBIT and Profit
ⓘUnderstanding Revenue, EBIT, and Income
Gain insights into PeptiDream, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by PeptiDream from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects PeptiDream’s net earnings, an ultimate measure of its financial health and profitability.
Yearly Analysis and Comparisons
Observe the yearly bars to understand the annual performance and growth of PeptiDream. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.
Utilizing Expectations for Investment
The expected values for the forthcoming years offer investors a glimpse into PeptiDream’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.
Investment Insights
Leveraging the comparison between Revenue and EBIT helps in assessing PeptiDream’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on PeptiDream’s growth potential.
PeptiDream Revenue, EBIT and net profit per share
| Date | PeptiDream Revenue | PeptiDream EBIT | PeptiDream Net Income |
|---|---|---|---|
| 2026e | 44.31 B undefined | 0 undefined | 12.92 B undefined |
| 2025e | 41.61 B undefined | 0 undefined | 11.57 B undefined |
| 2024e | 46.62 B undefined | 0 undefined | 14.85 B undefined |
| 2023 | 28.71 B undefined | 6.81 B undefined | 3.04 B undefined |
| 2022 | 26.85 B undefined | 8.97 B undefined | 7.55 B undefined |
| 2021 | 9.42 B undefined | 4.06 B undefined | 2.57 B undefined |
| 2020 | 11.68 B undefined | 6.99 B undefined | 4.45 B undefined |
| 2019 | 1.04 B undefined | -887.17 M undefined | -488.46 M undefined |
| 2018 | 7.22 B undefined | 3.58 B undefined | 2.77 B undefined |
| 2017 | 6.43 B undefined | 2.91 B undefined | 2.34 B undefined |
| 2016 | 4.9 B undefined | 2.49 B undefined | 1.89 B undefined |
| 2015 | 4.33 B undefined | 2.55 B undefined | 1.58 B undefined |
| 2014 | 2.47 B undefined | 1.39 B undefined | 1 B undefined |
| 2013 | 818.9 M undefined | 201.4 M undefined | 148.5 M undefined |
| 2012 | 678.3 M undefined | 160.8 M undefined | 137.2 M undefined |
| 2011 | 269 M undefined | -18.2 M undefined | 10 M undefined |
| 2010 | 601.5 M undefined | 348.6 M undefined | 176.1 M undefined |
| 2009 | 91.1 M undefined | -33.5 M undefined | -19 M undefined |
| 2008 | 86.9 M undefined | -22.5 M undefined | -21.9 M undefined |
| 2007 | 60.1 M undefined | 3.3 M undefined | 2.4 M undefined |
| Revenue | EBIT | Net Income | |
|---|---|---|---|
| 2007 | 60.1 M JPY | 3.3 M JPY | 2.4 M JPY |
| 2008 | 86.9 M JPY | -22.5 M JPY | -21.9 M JPY |
| 2009 | 91.1 M JPY | -33.5 M JPY | -19 M JPY |
| 2010 | 601.5 M JPY | 348.6 M JPY | 176.1 M JPY |
| 2011 | 269 M JPY | -18.2 M JPY | 10 M JPY |
| 2012 | 678.3 M JPY | 160.8 M JPY | 137.2 M JPY |
| 2013 | 818.9 M JPY | 201.4 M JPY | 148.5 M JPY |
| 2014 | 2.47 B JPY | 1.39 B JPY | 1 B JPY |
| 2015 | 4.33 B JPY | 2.55 B JPY | 1.58 B JPY |
| 2016 | 4.9 B JPY | 2.49 B JPY | 1.89 B JPY |
| 2017 | 6.43 B JPY | 2.91 B JPY | 2.34 B JPY |
| 2018 | 7.22 B JPY | 3.58 B JPY | 2.77 B JPY |
| 2019 | 1.04 B JPY | -887.17 M JPY | -488.46 M JPY |
| 2020 | 11.68 B JPY | 6.99 B JPY | 4.45 B JPY |
| 2021 | 9.42 B JPY | 4.06 B JPY | 2.57 B JPY |
| 2022 | 26.85 B JPY | 8.97 B JPY | 7.55 B JPY |
| 2023 | 28.71 B JPY | 6.81 B JPY | 3.04 B JPY |
| 2024e | 46.62 B JPY | 0 JPY | 14.85 B JPY |
| 2025e | 41.61 B JPY | 0 JPY | 11.57 B JPY |
| 2026e | 44.31 B JPY | 0 JPY | 12.92 B JPY |
PeptiDream stock margins JP3836750004 · A1W0KK
The PeptiDream margin analysis displays the gross margin, EBIT margin, as well as the profit margin of PeptiDream. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for PeptiDream.
3 years
5 years
10 years
25 Years
Max
Gross margin
EBIT margin
Profit margin
Details
Margin
ⓘUnderstanding Gross Margin
The gross margin, expressed as a percentage, delineates the gross profit made from the PeptiDream's sales revenue. A higher gross margin percentage indicates that the PeptiDream retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.
EBIT Margin Analysis
EBIT margin represents the PeptiDream's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.
Revenue Margin Insights
The revenue margin demonstrates the PeptiDream's total revenue generated. When comparing the revenue margin year over year, investors can gauge the PeptiDream's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.
Interpreting Expectations
The expected values for gross, EBIT, and revenue margins provide future financial outlook of the PeptiDream. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.
Comparative Analysis
Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the PeptiDream's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.
PeptiDream Margin History
| PeptiDream Gross margin | PeptiDream Profit margin | PeptiDream EBIT margin | PeptiDream Profit margin |
|---|---|---|---|
| 2026e | 59.97 % | 0 % | 29.15 % |
| 2025e | 59.97 % | 0 % | 27.79 % |
| 2024e | 59.97 % | 0 % | 31.85 % |
| 2023 | 59.97 % | 23.72 % | 10.57 % |
| 2022 | 67.46 % | 33.42 % | 28.13 % |
| 2021 | 74.6 % | 43.06 % | 27.31 % |
| 2020 | 81.61 % | 59.87 % | 38.09 % |
| 2019 | 35.28 % | -85.52 % | -47.09 % |
| 2018 | 77.12 % | 49.6 % | 38.39 % |
| 2017 | 72.33 % | 45.29 % | 36.34 % |
| 2016 | 72.22 % | 50.87 % | 38.62 % |
| 2015 | 74.9 % | 58.88 % | 36.54 % |
| 2014 | 70.84 % | 56.1 % | 40.58 % |
| 2013 | 61.56 % | 24.59 % | 18.13 % |
| 2012 | 60.55 % | 23.71 % | 20.23 % |
| 2011 | 37.77 % | -6.77 % | 3.72 % |
| 2010 | 80.2 % | 57.96 % | 29.28 % |
| 2009 | 30.95 % | -36.77 % | -20.86 % |
| 2008 | 43.96 % | -25.89 % | -25.2 % |
| 2007 | 51.58 % | 5.49 % | 3.99 % |
| Gross margin | EBIT margin | Profit margin | |
|---|---|---|---|
| 2007 | 51.58 % | 5.49 % | 3.99 % |
| 2008 | 43.96 % | -25.89 % | -25.2 % |
| 2009 | 30.95 % | -36.77 % | -20.86 % |
| 2010 | 80.2 % | 57.96 % | 29.28 % |
| 2011 | 37.77 % | -6.77 % | 3.72 % |
| 2012 | 60.55 % | 23.71 % | 20.23 % |
| 2013 | 61.56 % | 24.59 % | 18.13 % |
| 2014 | 70.84 % | 56.1 % | 40.58 % |
| 2015 | 74.9 % | 58.88 % | 36.54 % |
| 2016 | 72.22 % | 50.87 % | 38.62 % |
| 2017 | 72.33 % | 45.29 % | 36.34 % |
| 2018 | 77.12 % | 49.6 % | 38.39 % |
| 2019 | 35.28 % | -85.52 % | -47.09 % |
| 2020 | 81.61 % | 59.87 % | 38.09 % |
| 2021 | 74.6 % | 43.06 % | 27.31 % |
| 2022 | 67.46 % | 33.42 % | 28.13 % |
| 2023 | 59.97 % | 23.72 % | 10.57 % |
| 2024e | 59.97 % | 0 % | 31.85 % |
| 2025e | 59.97 % | 0 % | 27.79 % |
| 2026e | 59.97 % | 0 % | 29.15 % |
PeptiDream Aktienanalyse
What does PeptiDream do?
PeptiDream Inc is a Japanese biotech company specializing in novel therapeutics and drugs. The company was founded in 2006 by Professor Hiroaki Suga, who established the field of peptide synthesis at the University of Tokyo. Peptides are short chains of amino acids used in pharmaceutical development and diagnosis. PeptiDream uses a patented technology to generate billions of different peptides, which can then be systematically tested for functionality and applicability. The company also utilizes artificial intelligence and machine learning to specifically find compounds that can potentially treat cancer or neurodegenerative diseases. PeptiDream has four diverse business areas focusing on different applications. The first area is the identification of new drugs, where the company collaborates with several pharmaceutical and biotech firms to develop new compounds. The second area focuses on the development of peptide-based diagnostics. An example of this is the PeelAVERT technology, which identifies cancer-causing proteins through a "peeling process" of skin samples. This allows for personalized cancer treatment and improves success rates. The third area involves the development of agrochemicals. PeptiDream aims to replace chemical pesticides with biodegradable peptide-based compounds that have no negative impact on the environment. The fourth area aims to enhance quality of life through the use of peptides. The company focuses on compounds that can strengthen the immune system or slow down the aging process. PeptiDream has made several groundbreaking discoveries, including the PD-1 inhibitor technology for cancer treatment. This method uses peptides to activate the body's immune system and kill cancer cells. PD-1 inhibitors have shown promising results in clinical studies for lung cancer, kidney cancer, and other tumor types. PeptiDream has also developed a technology called "Peptide Discovery Platform System 2.0," which allows for the rapid generation and analysis of billions of diverse peptides. This method has been patented and enables PeptiDream to quickly focus on the development of new compounds. PeptiDream is a global leader in the development of peptide therapeutics and diagnostics. The company has earned an excellent reputation and collaborates closely with various research institutions, pharmaceutical companies, and biotech firms. PeptiDream also invests in training the next generation of scientists and strives to provide the industry and society with new compounds. PeptiDream ist eines der beliebtesten Unternehmen auf Eulerpool.com.Revenue Details
Understanding PeptiDream's Sales Figures
The sales figures of PeptiDream originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.
Year-to-Year Comparison
Analyzing PeptiDream’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.
Impact on Investments
Investors often scrutinize PeptiDream's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.
Interpreting Sales Fluctuations
Increases in PeptiDream’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.
Frequently Asked Questions about PeptiDream stock
How much was the turnover of the company PeptiDream compared to the previous year?
The revenue of PeptiDream has increased by 62.36% increased compared to the previous year.
What does revenue mean for investors?
The revenue of a company is an important indicator of its financial performance and attractiveness for investors.
Which factors influence the revenue of PeptiDream?
The revenue of PeptiDream is influenced by various factors, including the demand for its products and services, market conditions, and prices.
How is the revenue of PeptiDream measured?
Revenue is typically measured in units referring to the sale of goods and services provided by the company.
How does an increase in sales affect investments?
An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.
What are the possible risks associated with a declining revenue?
A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.
Why is the sales revenue of PeptiDream so important for investors?
The revenue of PeptiDream is an important indicator of financial performance and attractiveness for investors.
What strategic measures can a company take to increase revenue?
A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.
How much dividend does PeptiDream pay?
Over the past 12 months, PeptiDream paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, PeptiDream is expected to pay a dividend of 0 JPY.
What is the dividend yield of PeptiDream?
The current dividend yield of PeptiDream is .
When does PeptiDream pay dividends?
PeptiDream pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of PeptiDream?
PeptiDream paid dividends every year for the past 0 years.
What is the dividend of PeptiDream?
For the upcoming 12 months, dividends amounting to 0 JPY are expected. This corresponds to a dividend yield of 0 %.
In which sector is PeptiDream located?
PeptiDream is assigned to the 'Health' sector.
Wann musste ich die Aktien von PeptiDream kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of PeptiDream from 11/19/2024 amounting to 0 JPY, you needed to have the stock in your portfolio before the ex-date on 11/19/2024.
When did PeptiDream pay the last dividend?
The last dividend was paid out on 11/19/2024.
What was the dividend of PeptiDream in the year 2023?
In the year 2023, PeptiDream distributed 0 JPY as dividends.
In which currency does PeptiDream pay out the dividend?
The dividends of PeptiDream are distributed in JPY.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von PeptiDream
Our stock analysis for PeptiDream Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of PeptiDream Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
